Cargando…

Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease

Extracellular vesicles (EVs) play key roles in glioblastoma (GBM) biology and represent novel sources of biomarkers that are detectable in the peripheral circulation. Despite this notionally non-invasive approach to assess GBM tumours in situ, a comprehensive GBM EV protein signature has not been de...

Descripción completa

Detalles Bibliográficos
Autores principales: Mallawaaratchy, Duthika M., Hallal, Susannah, Russell, Ben, Ly, Linda, Ebrahimkhani, Saeideh, Wei, Heng, Christopherson, Richard I., Buckland, Michael E., Kaufman, Kimberley L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5306193/
https://www.ncbi.nlm.nih.gov/pubmed/27770278
http://dx.doi.org/10.1007/s11060-016-2298-3
_version_ 1782507148818776064
author Mallawaaratchy, Duthika M.
Hallal, Susannah
Russell, Ben
Ly, Linda
Ebrahimkhani, Saeideh
Wei, Heng
Christopherson, Richard I.
Buckland, Michael E.
Kaufman, Kimberley L.
author_facet Mallawaaratchy, Duthika M.
Hallal, Susannah
Russell, Ben
Ly, Linda
Ebrahimkhani, Saeideh
Wei, Heng
Christopherson, Richard I.
Buckland, Michael E.
Kaufman, Kimberley L.
author_sort Mallawaaratchy, Duthika M.
collection PubMed
description Extracellular vesicles (EVs) play key roles in glioblastoma (GBM) biology and represent novel sources of biomarkers that are detectable in the peripheral circulation. Despite this notionally non-invasive approach to assess GBM tumours in situ, a comprehensive GBM EV protein signature has not been described. Here, EVs secreted by six GBM cell lines were isolated and analysed by quantitative high-resolution mass spectrometry. Overall, 844 proteins were identified in the GBM EV proteome, of which 145 proteins were common to EVs secreted by all cell lines examined; included in the curated EV compendium (Vesiclepedia_559; http://microvesicles.org). Levels of 14 EV proteins significantly correlated with cell invasion (invadopodia production; r(2) > 0.5, p < 0.05), including several proteins that interact with molecules responsible for regulating invadopodia formation. Invadopodia, actin-rich membrane protrusions with proteolytic activity, are associated with more aggressive disease and are sites of EV release. Gene levels corresponding to invasion-related EV proteins showed that five genes (annexin A1, actin-related protein 3, integrin-β1, insulin-like growth factor 2 receptor and programmed cell death 6-interacting protein) were significantly higher in GBM tumours compared to normal brain in silico, with common functions relating to actin polymerisation and endosomal sorting. We also show that Cavitron Ultrasonic Surgical Aspirator (CUSA) washings are a novel source of brain tumour-derived EVs, demonstrated by particle tracking analysis, TEM and proteome profiling. Quantitative proteomics corroborated the high levels of proposed invasion-related proteins in EVs enriched from a GBM compared to low-grade astrocytoma tumour. Large-scale clinical follow-up of putative biomarkers, particularly the proposed survival marker annexin A1, is warranted. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11060-016-2298-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5306193
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-53061932017-02-24 Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease Mallawaaratchy, Duthika M. Hallal, Susannah Russell, Ben Ly, Linda Ebrahimkhani, Saeideh Wei, Heng Christopherson, Richard I. Buckland, Michael E. Kaufman, Kimberley L. J Neurooncol Laboratory Investigation Extracellular vesicles (EVs) play key roles in glioblastoma (GBM) biology and represent novel sources of biomarkers that are detectable in the peripheral circulation. Despite this notionally non-invasive approach to assess GBM tumours in situ, a comprehensive GBM EV protein signature has not been described. Here, EVs secreted by six GBM cell lines were isolated and analysed by quantitative high-resolution mass spectrometry. Overall, 844 proteins were identified in the GBM EV proteome, of which 145 proteins were common to EVs secreted by all cell lines examined; included in the curated EV compendium (Vesiclepedia_559; http://microvesicles.org). Levels of 14 EV proteins significantly correlated with cell invasion (invadopodia production; r(2) > 0.5, p < 0.05), including several proteins that interact with molecules responsible for regulating invadopodia formation. Invadopodia, actin-rich membrane protrusions with proteolytic activity, are associated with more aggressive disease and are sites of EV release. Gene levels corresponding to invasion-related EV proteins showed that five genes (annexin A1, actin-related protein 3, integrin-β1, insulin-like growth factor 2 receptor and programmed cell death 6-interacting protein) were significantly higher in GBM tumours compared to normal brain in silico, with common functions relating to actin polymerisation and endosomal sorting. We also show that Cavitron Ultrasonic Surgical Aspirator (CUSA) washings are a novel source of brain tumour-derived EVs, demonstrated by particle tracking analysis, TEM and proteome profiling. Quantitative proteomics corroborated the high levels of proposed invasion-related proteins in EVs enriched from a GBM compared to low-grade astrocytoma tumour. Large-scale clinical follow-up of putative biomarkers, particularly the proposed survival marker annexin A1, is warranted. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11060-016-2298-3) contains supplementary material, which is available to authorized users. Springer US 2016-10-21 2017 /pmc/articles/PMC5306193/ /pubmed/27770278 http://dx.doi.org/10.1007/s11060-016-2298-3 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Laboratory Investigation
Mallawaaratchy, Duthika M.
Hallal, Susannah
Russell, Ben
Ly, Linda
Ebrahimkhani, Saeideh
Wei, Heng
Christopherson, Richard I.
Buckland, Michael E.
Kaufman, Kimberley L.
Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease
title Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease
title_full Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease
title_fullStr Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease
title_full_unstemmed Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease
title_short Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease
title_sort comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease
topic Laboratory Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5306193/
https://www.ncbi.nlm.nih.gov/pubmed/27770278
http://dx.doi.org/10.1007/s11060-016-2298-3
work_keys_str_mv AT mallawaaratchyduthikam comprehensiveproteomeprofilingofglioblastomaderivedextracellularvesiclesidentifiesmarkersformoreaggressivedisease
AT hallalsusannah comprehensiveproteomeprofilingofglioblastomaderivedextracellularvesiclesidentifiesmarkersformoreaggressivedisease
AT russellben comprehensiveproteomeprofilingofglioblastomaderivedextracellularvesiclesidentifiesmarkersformoreaggressivedisease
AT lylinda comprehensiveproteomeprofilingofglioblastomaderivedextracellularvesiclesidentifiesmarkersformoreaggressivedisease
AT ebrahimkhanisaeideh comprehensiveproteomeprofilingofglioblastomaderivedextracellularvesiclesidentifiesmarkersformoreaggressivedisease
AT weiheng comprehensiveproteomeprofilingofglioblastomaderivedextracellularvesiclesidentifiesmarkersformoreaggressivedisease
AT christophersonrichardi comprehensiveproteomeprofilingofglioblastomaderivedextracellularvesiclesidentifiesmarkersformoreaggressivedisease
AT bucklandmichaele comprehensiveproteomeprofilingofglioblastomaderivedextracellularvesiclesidentifiesmarkersformoreaggressivedisease
AT kaufmankimberleyl comprehensiveproteomeprofilingofglioblastomaderivedextracellularvesiclesidentifiesmarkersformoreaggressivedisease